Emily Hanzlik1, Stacey E Woodrome2, Mohamed Abdel-Baki3, Thomas J Geller4, Samer K Elbabaa5. 1. Saint Louis University School of Medicine, Saint Louis, MO, USA. 2. Department of Psychology, SSM Cardinal Glennon Children's Medical Center, Saint Louis, MO, USA. 3. Division of Hematology/Oncology, Department of Pediatrics, Saint Louis University School of Medicine, Saint Louis, MO, USA. 4. Division of Child Neurology, Department of Neurology and Psychiatry, Saint Louis University School of Medicine, Saint Louis, MO, USA. 5. Division of Pediatric Neurosurgery, Department of Neurological Surgery, Saint Louis University School of Medicine, 1465 South Grand Blvd, Suite 2705, Saint Louis, MO, 63104, USA. selbabaa@slu.edu.
Abstract
PURPOSE: Central nervous system tumors are the most common solid tumors in the pediatric population. As children with central nervous system (CNS) tumors are surviving into adolescence and adulthood, more research is being focused on the long-term cognitive outcomes of the survivors. This review examines the literature on different cognitive outcomes of survivors of different childhood posterior fossa CNS tumor types. METHODS: The authors reviewed the literature for articles published from 2000 to 2012 about long-term neuropsychological outcomes of children diagnosed with posterior fossa brain tumors before the age of 18, which distinguished between histological tumor types, and had a minimum follow-up of 3 years. RESULTS: The literature search returned 13 articles, and a descriptive analysis was performed comparing intelligence quotient (IQ), attention/executive function, and memory components of 456 survivors of childhood posterior fossa tumors. Four articles directly compared astrocytoma and medulloblastoma survivors and showed medulloblastoma survivors fared worse in IQ, attention/executive function, and memory measurements. Five articles reporting medulloblastomas found IQ, attention, and memory scores to be significantly below the standardized means. Articles examining astrocytoma survivors found IQ scores within the normal range for the population. Survivors of ependymomas reported 2/23 survivors impaired on IQ scores, while a second study reported a significant number of ependymoma survivors lower than the expected population norm. CONCLUSIONS: Tumor histopathology and the type of postoperative adjuvant therapy seem to have a significant impact on the long-term neuropsychological complications of pediatric posterior fossa CNS tumor survivors. Age at diagnosis and treatment factors are important variables that affect the outcomes of the survivors.
PURPOSE:Central nervous system tumors are the most common solid tumors in the pediatric population. As children with central nervous system (CNS) tumors are surviving into adolescence and adulthood, more research is being focused on the long-term cognitive outcomes of the survivors. This review examines the literature on different cognitive outcomes of survivors of different childhood posterior fossa CNS tumor types. METHODS: The authors reviewed the literature for articles published from 2000 to 2012 about long-term neuropsychological outcomes of children diagnosed with posterior fossa brain tumors before the age of 18, which distinguished between histological tumor types, and had a minimum follow-up of 3 years. RESULTS: The literature search returned 13 articles, and a descriptive analysis was performed comparing intelligence quotient (IQ), attention/executive function, and memory components of 456 survivors of childhood posterior fossa tumors. Four articles directly compared astrocytoma and medulloblastoma survivors and showed medulloblastoma survivors fared worse in IQ, attention/executive function, and memory measurements. Five articles reporting medulloblastomas found IQ, attention, and memory scores to be significantly below the standardized means. Articles examining astrocytoma survivors found IQ scores within the normal range for the population. Survivors of ependymomas reported 2/23 survivors impaired on IQ scores, while a second study reported a significant number of ependymoma survivors lower than the expected population norm. CONCLUSIONS:Tumor histopathology and the type of postoperative adjuvant therapy seem to have a significant impact on the long-term neuropsychological complications of pediatric posterior fossa CNS tumor survivors. Age at diagnosis and treatment factors are important variables that affect the outcomes of the survivors.
Authors: S L Palmer; O Goloubeva; W E Reddick; J O Glass; A Gajjar; L Kun; T E Merchant; R K Mulhern Journal: J Clin Oncol Date: 2001-04-15 Impact factor: 44.544
Authors: R K Mulhern; S L Palmer; W E Reddick; J O Glass; L E Kun; J Taylor; J Langston; A Gajjar Journal: J Clin Oncol Date: 2001-01-15 Impact factor: 44.544
Authors: Iska Moxon-Emre; Eric Bouffet; Michael D Taylor; Normand Laperriere; Nadia Scantlebury; Nicole Law; Brenda J Spiegler; David Malkin; Laura Janzen; Donald Mabbott Journal: J Clin Oncol Date: 2014-02-10 Impact factor: 44.544
Authors: Eliana A Quintero-Gallego; Carlos M Gómez; Encarnación Vaquero Casares; Javier Márquez; Fco Javier Pérez-Santamaría Journal: Behav Brain Funct Date: 2006-03-15 Impact factor: 3.759
Authors: Angela C Summers; Joseph Snow; Edythe Wiggs; Alexander G Liu; Camilo Toro; Andrea Poretti; Wadih M Zein; Brian P Brooks; Melissa A Parisi; Sara Inati; Dan Doherty; Meghana Vemulapalli; Jim C Mullikin; Thierry Vilboux; William A Gahl; Meral Gunay-Aygun Journal: Am J Med Genet A Date: 2017-05-12 Impact factor: 2.802
Authors: Mathieu Decock; Robin De Wilde; Ruth Van der Looven; Catharine Vander Linden Journal: Int J Environ Res Public Health Date: 2022-06-09 Impact factor: 4.614
Authors: C A P F Alves; U Löbel; J S Martin-Saavedra; S Toescu; M H Tsunemi; S R Teixeira; K Mankad; D Hargrave; T S Jacques; C da Costa Leite; F G Gonçalves; A Vossough; F D'Arco Journal: AJNR Am J Neuroradiol Date: 2021-03-04 Impact factor: 3.825
Authors: Allison P Fisher; Jamie Patronick; Cynthia A Gerhardt; Krestin Radonovich; Ralph Salloum; Shari L Wade Journal: Pediatr Blood Cancer Date: 2021-05-24 Impact factor: 3.838
Authors: Elodie Doger de Speville; Charlotte Robert; Martin Perez-Guevara; Antoine Grigis; Stephanie Bolle; Clemence Pinaud; Christelle Dufour; Anne Beaudré; Virginie Kieffer; Audrey Longaud; Jacques Grill; Dominique Valteau-Couanet; Eric Deutsch; Dimitri Lefkopoulos; Catherine Chiron; Lucie Hertz-Pannier; Marion Noulhiane Journal: Front Oncol Date: 2017-08-18 Impact factor: 6.244
Authors: Holger Ottensmeier; Paul G Schlegel; Matthias Eyrich; Johannes E Wolff; Björn-Ole Juhnke; Katja von Hoff; Stefanie Frahsek; Rene Schmidt; Andreas Faldum; Gudrun Fleischhack; Andre von Bueren; Carsten Friedrich; Anika Resch; Monika Warmuth-Metz; Jürgen Krauss; Rolf D Kortmann; Udo Bode; Joachim Kühl; Stefan Rutkowski Journal: PLoS One Date: 2020-01-23 Impact factor: 3.240